Navitor Pharmaceuticals Names Randy Owen Chief Medical Officer

Xconomy Boston — 

Navitor Pharmaceuticals has appointed James Randall “Randy” Owen to serve as its chief medical officer, the same position he held at Acadia Pharmaceuticals. Owen’s experience also includes roles at Lundbeck, Abbott (NYSE: ABT), Merck (NYSE: MRK), and Bristol-Myers Squibb (NYSE: BMY). Cambridge, MA-based Navitor is developing drugs that target a cellular signaling pathway known as mTORC1 in order to treat age-related diseases.